Factbox-Global drugmakers rush to boost US presence as tariff threat looms
PositiveFinancial Markets

In response to looming tariff threats, global drugmakers are rapidly expanding their presence in the U.S. This surge is significant as it not only reflects the industry's adaptability but also highlights the importance of the U.S. market in the global pharmaceutical landscape. By increasing their investments and operations in the U.S., these companies aim to mitigate potential impacts from tariffs, ensuring they remain competitive and can continue to innovate in drug development.
— Curated by the World Pulse Now AI Editorial System